ReviewBritish journal of haematology2012
Emerging pathogens and their implications for the blood supply and transfusion transmitted infections.
Review in British journal of haematology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Evidence of pediatric sepsis caused by a drug resistantEmerging microbes & infections · 2022Article
- Assessing quality of blood components derived from whole blood treated with riboflavin and ultraviolet light and separated with a fully automated device.Blood transfusion = Trasfusione del sangue · 2022Article
- An overview of some potential immunotherapeutic options against COVID-19.International immunopharmacology · 2021Review
- Metagenomic analysis and identification of emerging pathogens in blood from healthy donors.Scientific reports · 2020Article
- Current status of potential therapeutic candidates for the COVID-19 crisis.Brain, behavior, and immunity · 2020Review
- Medical Management of COVID-19: Evidence and Experience.Journal of clinical medicine research · 2020Review
- Clinical Utility of Autologous Salvaged Blood: a Review.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2020Review
- Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives.Frontiers in pharmacology · 2020Review
- Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products.Frontiers in medicine · 2018Review
- Transfusion-related immunomodulation: a reappraisal.Current opinion in hematology · 2017Review
- Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.Blood transfusion = Trasfusione del sangue · 2017Review
- Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.Transfusion medicine reviews · 2016Article
- Convalescent plasma: new evidence for an old therapeutic tool?Blood transfusion = Trasfusione del sangue · 2016Review
- Improving platelet transfusion safety: biomedical and technical considerations.Blood transfusion = Trasfusione del sangue · 2016Review
- Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome.PloS one · 2016Article
- Hepatitis E virus infection: Epidemiology and treatment implications.World journal of virology · 2015Review
- Article
- Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion.New biotechnology · 2015Review
- Ebola virus convalescent blood products: where we are now and where we may need to go.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2014Review
- “Go no Go” in plasma fractionation in the world’s emerging economies: still a question asked 70 years after the COHN process was developed!Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The threat of infection by conventional transfusion-transmitted agents has been essentially eliminated from the blood supply in developed countries, thus focusing attention on the potential risk from emerging infections. Over recent years, actions have been taken to manage a number of such risks to blood safety. These illustrate the inherent variability of the agents concerned and of the measures needed to define and control the risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.